Our governance
Share ownership control bodies
Pierre Fabre Foundation
The Pierre Fabre Foundation is the Group's majority shareholder. Since the Foundation is dedicated first and foremost to its public-interest mission, it delegates supervision of Group management to its subsidiary, Pierre Fabre Participations.
Pierre Fabre Participations
This controlling company approves the Group's strategy, appoints its main executives and ensures that the continuity mission set out by Mr. Pierre Fabre himself is observed:
- Ensuring the Group's independence
- Maintaining both areas of activity (Pharmaceuticals and Dermo-Cosmetics)
- Investing heavily in R&D
- Prioritizing long-term goals rather than short-term financial results
- Maintaining the Group's footprint in its home region and its culture of corporate social responsibility
- Enabling the Pierre Fabre Foundation to pursue its objectives through a suitable dividend payment policy
Operating companies
Pierre Fabre SA
Pierre Fabre S.A. is the Group's holding company. It establishes the Group's overall strategy, consolidates and coordinates our activities and hosts shared services and support functions. Pierre Fabre Médicament and Pierre Fabre Dermo-Cosmétique are the main subsidiaries of Pierre Fabre S.A., respectively in charge of the pharmaceutical and dermo-cosmetics businesses.
Pierre Fabre SA Supervisory Board
Chairman (non-executive) : Roch Doliveux
Vice-Chairman (non-executive) : Pierre-Yves Revol
Board members: Marie-Anne AYMERICH, Jean-Laurent BONNAFE, Isabelle GIROLAMI, Marie-France MARCHAND BAYLET, Rachel MAROUANI, Eduardo SANCHIZ, Olivier SADRAN, Agathe AMARA and Alexandre GIRAUDON.
Employee and employee shareholder scheme representatives: Agathe AMARA-COLOMBIE, Jean-François COURET and Alexandre GIRAUDON.
The Pierre Fabre Supervisory Board has formed three committees:
- The Audit Committee chaired by Isabelle GIROLAMI
The main missions of this committee are to examine the accounts and monitor issues concerning the generation and control of accounting and financial information. The Audit Committee is also responsible for checking the effectiveness of the Group's risk management and internal control systems. Its members are: Isabelle GIROLAMI, Pierre-Yves REVOL, Eduardo SANCHIZ and Jean-François COURET. - Nomination and Remuneration Committee, chaired by Jean-Jacques BERTRAND
This committee assists the board in selecting its members and corporate executives, and formulates recommendations concerning their remuneration.
Its members are: Jean-Jacques BERTRAND, Roch DOLIVEUX and Pierre-Yves REVOL. - Strategic Committee chaired by Roch DOLIVEUX
The aim of this committee is to issue opinions on the Group's main strategic choices, in particular in terms of R&D, and on its business development policy, proposed by executive management to the Supervisory Board.
Its members are:Roch DOLIVEUX, Marie-Anne AYMERICH, Jean-Laurent BONNAFE, Isabelle GIROLAMI, Rachel MAROUANI, Pierre-Yves REVOL, Olivier SADRAN and Eduardo SANCHIZ.
The Group's Executive Committee
Eric DUCOURNAU is the Group's CEO. The members of the Executive Committee are:
- Núria PEREZ-CULLELL (Dermo-Cosmetics & Personal Care Business Unit CEO)
- Jean-Luc LOWINSKI (Medical Care Business Unit CEO)
- Eric GOUY (Administrative, Finance and Legal Senior Vice President)
- Agnès PARK (Human Resources Senior Vice President)
- Giuseppe MELE (International, Export and E-Business Business Unit CEO)
- Vincent HURAUX (Operations Business Unit CEO)
